Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat

0
127

Twenty-five years after the U.S. Food and Drug Administration bypassed safety concerns to approve what has become the most popular abortion method on the market, the agency greenlit a generic version of mifepristone manufactured by a company committed to “normalizing” abortion for all.

The news broke mere weeks after the FDA formally committed to re-examining the factors that could prompt it to limit, if not revoke, permission for mifepristone’s prevalence in the U.S.

Health and Human Services Secretary Robert F. Kennedy Jr. confirmed to the Senate Finance Committee on Sept. 4 that the FDA was evaluating “new data” on mifepristone.

“We know that during the Biden administration, they actually twisted the data to bury one of the safety signals with a very high safety signal, around 11 percent,” Kennedy added.

In a joint letter to 22 Republican…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here